World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
41017
World Ranking
7620
National Ranking
3968

David B. Clifford publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David B. Clifford sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 383 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David B. Clifford D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David B. Clifford sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David B. Clifford is affiliated with Washington University in St. Louis in the United States. Their academic work spans extensively in the field of medicine, focusing particularly on infectious diseases, neurology, virology, epidemiology, and oncology. Over the course of their career, they have contributed to a wide range of research topics primarily linked to HIV treatment and complications, neurodegenerative diseases, and viral infections.

Key areas of research include:

  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • Polyomavirus and related diseases
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • HIV/AIDS Research and Interventions
  • Neuroinflammation and Neurodegeneration Mechanisms

The scientist has published notably in various peer-reviewed journals, with frequent venues including:

  • Alzheimer's & Dementia
  • UNC Libraries
  • Clinical Infectious Diseases
  • Neurology
  • Annals of Neurology

David B. Clifford has co-authored numerous papers alongside several key collaborators. The most frequent co-authors are:

  • Ronald J. Ellis
  • Scott Letendre
  • Christina M. Marra
  • Benjamin B. Gelman
  • Eric McDade

Recent scholarly works include the following publications:

  • Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease, 2020, Clinical Infectious Diseases
  • Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease, 2020, Arthritis Care & Research
  • Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease, 2020, Arthritis & Rheumatology
  • Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology, 2020, Neurology
  • Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors, 2022, Annals of Neurology

In addition to research articles, David B. Clifford has contributed to book publications, including a title published by the Royal Society of Chemistry:

  • Carbon Dioxide Electrochemistry, 2020

Best Publications

  • Updated research nosology for HIV-associated neurocognitive disorders

    A. Antinori;G. Arendt;J. T. Becker;B. J. Brew

  • HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

    R. K. Heaton;D. B. Clifford;D. R. Franklin;S. P. Woods

  • HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

    Robert K. Heaton;Donald R. Franklin;Ronald J. Ellis;J. Allen McCutchan

  • Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

    Scott Letendre;Jennifer Marquie-Beck;Edmund Capparelli;Brookie Best

  • Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

    Tarek A. Yousry;Eugene O. Major;Caroline Ryschkewitsch;Gary Fahle

  • Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    David W Haas;Heather J Ribaudo;Richard B Kim;Camlin Tierney

  • PML diagnostic criteria: Consensus statement from the AAN neuroinfectious disease section

    Joseph R. Berger;Allen J. Aksamit;David B. Clifford;Larry Davis

  • Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

    David B Clifford;Andrea DeLuca;David M Simpson;Gabriele Arendt

  • HIV-associated neurocognitive disorder

    David B Clifford;Beau M Ances

  • HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group

    Kevin P. High;Mark Brennan-Ing;David B. Clifford;Mardge H. Cohen

  • CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.

    Ronald J. Ellis;Jayraan Badiee;Florin Vaida;Scott Letendre

  • The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures.

    D.B. Clifford;J.W. Olney;A. Maniotis;R.C. Collins

  • Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study

    Robert K. Heaton;Donald R. Franklin;Reena Deutsch;Scott Letendre

  • Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

    Christina M. Marra;Yu Zhao;David B. Clifford;Scott Letendre

  • Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

    Ludwig Kappos;David Bates;Gilles Edan;Mefkûre Eraksoy

  • Continued High Prevalence and Adverse Clinical Impact of Human Immunodeficiency Virus–Associated Sensory Neuropathy in the Era of Combination Antiretroviral Therapy: The CHARTER Study

    Ronald J. Ellis;Debralee Rosario;David B. Clifford;Justin C. McArthur

  • Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

    Igor Grant;Donald R. Franklin;Reena Deutsch;Steven P. Woods

  • A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection

    J. C. McArthur;C. Yiannoutsos;D. M. Simpson;B. T. Adornato

  • Failure of Cytarabine in Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection

    Colin D. Hall;Urania Dafni;David Simpson;David Clifford

  • Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals

    David B. Clifford;Scott Evans;Yijun Yang;Edward P. Acosta

Frequent Co-Authors

Ronald J. Ellis
Ronald J. Ellis University of California, San Diego
Justin C. McArthur
Justin C. McArthur Johns Hopkins University School of Medicine
Igor Grant
Igor Grant University of California, San Diego
Benjamin B. Gelman
Benjamin B. Gelman The University of Texas Medical Branch at Galveston
Susan Morgello
Susan Morgello Icahn School of Medicine at Mount Sinai
Ann C. Collier
Ann C. Collier University of Washington
Scott Letendre
Scott Letendre University of California, San Diego
Robert K. Heaton
Robert K. Heaton University of California, San Diego
J. Allen McCutchan
J. Allen McCutchan University of California, San Diego
Donald Franklin
Donald Franklin University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a medical career but want to explore broader healthcare opportunities, online degrees can be a flexible and affordable option. Many students start with a health administration degree, opening doors to leadership roles in hospitals, clinics, or insurance companies.

For those aiming for advanced positions, the cheapest master's in healthcare administration programs offer cost-effective ways to specialize further and boost your earning potential. These programs focus on healthcare policy, management, and organizational leadership.

Thinking clinically? You might consider the most affordable online dnp programs to pursue advanced nursing roles, such as nurse practitioner or healthcare educator. Alternatively, if pharmacy interests you, there are options like a 3-year online pharmd for those seeking a fast-track to a Doctor of Pharmacy.

With so many paths available online, pursuing a medical or allied health career has never been more accessible or flexible.

Best Scientists Citing David B. Clifford

Trending Scientists

Recently Published Articles